Craft
Biora Therapeutics

Biora Therapeutics

Patent Families for Molecular Testing Technology Patent Portfolio

17

FY, 2021

Revenue

$1.2 M

FY, 2021

Market Capitalization

$144.8 M

2022-07-08

Biora Therapeutics Summary

Company summary

Overview
Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services. It develops and designs oral biotherapeutics by combining of drug therapies and smart capsule technology. The company provides capsules for gastrointestinal (GI) and inflammatory bowel diseases.
Type
Public
Status
Active
Founded
2010
HQ
San Diego, CA, US | view all locations
Website
https://www.bioratherapeutics.com
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key people

  • Adi Mohanty

    Adi Mohanty, Chief Executive Officer & Board Member

  • Eric d'Esparbes

    Eric d'Esparbes, Chief Financial Officer

  • Paul Shabram

    Paul Shabram, Head of Technical Operations

  • Robyn Hatton

    Robyn Hatton, Head of Human Resources

Operating MetricsView all

Patents and Patent Applications

350
41.7%

FY, 2021

Patent Families for Molecular Testing Technology Patent Portfolio

17

FY, 2021

Patent Families for Drug-Device and Diagnostics Device Patent Portfolio

70

FY, 2021

LocationsView all

2 locations detected

  • San Diego, CA HQ

    United States

    4330 La Jolla Village Drive, Suite 300

  • San Diego, CA

    United States

    10070 Carroll Canyon Rd #100

Biora Therapeutics Financials

Summary financials

Revenue (Q3, 2022)
$10.0M
Net income (Q3, 2022)
($5.1M)
EBIT (Q3, 2022)
($13.9M)

Footer menu